• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION ELUVIATM DRUG-ELUTING VASCULAR STENT SYSTEM; STENT, SUPERFICIAL FEMORAL ARTERY, DRUG-ELUTING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION ELUVIATM DRUG-ELUTING VASCULAR STENT SYSTEM; STENT, SUPERFICIAL FEMORAL ARTERY, DRUG-ELUTING Back to Search Results
Model Number 24620
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Reocclusion (1985)
Event Date 11/02/2018
Event Type  Injury  
Manufacturer Narrative
Age at the time of event: (b)(6) years old at the time of enrollment.Device is a combination product.
 
Event Description
It was reported that restenosis occurred.On (b)(6) 2016, the patent was enrolled in the imperial study and the index procedure was performed the same day.The target lesion was located in the right leg mid superficial femoral artery (sfa) with 100% stenosis and was 125mm long with a proximal reference vessel diameter of 4mm and distal vessel diameter of 4mm and was classified as tasc ii d lesion.The lesion was treated with pre-dilatation and placement of a 6.0 x 150mm study stent.Following post dilatation, residual stenosis was 0%.On (b)(6) 2018, during the 24 month follow up, dus was performed and revealed 50-99% in-stent restenosis of the previously placed study stent in the proximal portion of the right sfa - neointimal hyperplasia.On (b)(6) 2018, the patient was hospitalized for further evaluation and treatment.On the same day, 80% in-stent restenosis of the previously placed study stent in the proximal portion of the right sfa was treated with laser athrectomy and placement of a 6 x 40mm zilver stent.Post dilatation, there was no evidence of embolization or dissection.The patient was discharged on the same day on dapt.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ELUVIATM DRUG-ELUTING VASCULAR STENT SYSTEM
Type of Device
STENT, SUPERFICIAL FEMORAL ARTERY, DRUG-ELUTING
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
Manufacturer (Section G)
BOSTON SCIENTIFIC SCIMED, INC
two scimed place
maple grove MN 55311
Manufacturer Contact
sonali arangil
two scimed place
maple grove, MN 55311
6515827403
MDR Report Key8168912
MDR Text Key130479456
Report Number2134265-2018-64286
Device Sequence Number1
Product Code NIU
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P180011
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Physician
Type of Report Initial
Report Date 12/17/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/17/2018
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date01/31/2017
Device Model Number24620
Device Catalogue Number24620
Device Lot Number18822230
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received12/11/2018
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-